Treatment with the Radiolabelled Somatostatin Analog 177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

M Sansovini, S Severi, A Ambrosetti, M Monti… - …, 2013 - karger.com
Background: We evaluated the activity and safety profile of 177 Lu-DOTATATE peptide
receptor radionuclide therapy (Lu-PRRT) in patients with advanced G1-G2 pancreatic …

177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study

G Paganelli, M Sansovini, A Ambrosetti… - European journal of …, 2014 - Springer
Purpose We evaluated the activity and safety profile of 177 Lu-Dotatate peptide receptor
radionuclide therapy (Lu-PRRT) in patients with advanced, well-differentiated (G1-G2) …

Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index

…, A Ianniello, M Sansovini, A Ambrosetti… - European journal of …, 2018 - Springer
Purpose In the 2010 WHO classification, a Ki-67 proliferation index of 20% is the cut-off between
intermediate-grade and high-grade gastroenteropancreatic neuroendocrine neoplasia (…

[HTML][HTML] School burnout, relational, and organizational factors

S Parrello, A Ambrosetti, I Iorio, L Castelli - Frontiers in psychology, 2019 - frontiersin.org
Work stress and burnout affect teachers to a significant extent. The objective of this study is
to evaluate and compare the impact of relational and organizational factors on teacher …

[PDF][PDF] ÜGK–COFO–VeCoF 2016 results: Technical appendices

…, M Verner, F Petrucci, D Angelone, A Ambrosetti - 2019 - zora.uzh.ch
The ÜGK social background index (or socioeconomic status-SES) is a composite score. Its
calculation is based on three indicators: the highest parental occupational status, the highest …

Retreatment with low dose 177Lu-dotatate (Lu-PRRT), in patients with GEP NENs: A prospective feasibility and activity evaluation

…, L Bodei, M Sansovini, A Ianniello, A Ambrosetti… - 2014 - Soc Nuclear Med
391 Objectives Peptide Receptor Radionuclide Therapy (PRRT) is one of the most active
therapies in patients (pt.) with disseminated or inoperable Gastro-Entero-Pancreatic (GEP) …

Personalized 177Lu-dotatate treatment of advanced P-NENs and the value of 18F-FDG PET-CT as a prognostic factor in a long term follow up: our experience.

…, M Sansovini, A Ianniello, S Nicolini, A Ambrosetti… - 2016 - Soc Nuclear Med
630 Objectives We evaluated long-term efficacy and toxicity of tailored 177Lu-dotatate (177Lu-PRRT)
therapy in 65 consecutive patients with G1-G2 pancreatic neuroendocrine tumors (…

The school effect on mathematics performance in PISA 2012: A comparison between two cantons in Switzerland

A Ambrosetti, F Petrucci, S Fenaroli, M Egloff - Swiss journal of educational …, 2022 - sjer.ch
Through this research, we explored the relationship between student achievement and school
environment. We compared mathematics scores from the PISA test in Ticino and Geneva. …

[PDF][PDF] PISA 2015: ExPECTATIONS ABOuT FuTuRE EduCATION ANd LIFE SATISFACTION OF SWISS STudENTS

A Ambrosetti, F Crotta, S Zampieri - Well-being in education systems - supsi.ch
The Program for International Student Assessment (PISA) is a triennial survey promoted by
the Organization for Economic Co-operation and Development (OECD) that aims to evaluate …

[PDF][PDF] Giovanni Paganelli, Maddalena Sansovini, Alice Ambrosetti, Stefano Severi, Manuela Monti, Emanuela

CD Scarpi - academia.edu
Purpose We evaluated the activity and safety profile of 177Lu-Dotatate peptide receptor
radionuclide therapy (Lu-PRRT) in patients with advanced, well-differentiated (G1-G2) …